Mycophenolate sodium versus Everolimus or Cyclosporine with Allograft Nephropathy as Outcome

Completed

• Conditions: Renal transplant; Transplanted organs and tissue status; Surgery

• Registration Number: ISRCTN69188731
• Lead Sponsor: Academic Medical Center (AMC), Renal Transplant Unit (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-02-14
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 255

Inclusion Criteria

1. First or second renal transplant
2. Female or male 18-70 years old
3. Cadaveric or non-HLA identical living donor
4. Understands risks and purpose of study
5. Written informed consent

Exclusion Criteria

1. Double kidney transplants, kidney-pancreas transplants, 3rd or 4th transplant
2. PRA >50% historic or current
3. Pregnancy or unwilling to use contraception during the study
4. Cholesterol >8.5 mmol/l
5. History of therapy resistance against HMG co-reductase inhibitors

Study & Design

• Study Type: Interventional
• Study Design: Not specified